CVE-2021-43935
Published: Dec 15, 2021
Modified: Sep 16, 2024
CVSS v3.1
8.1
Description
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
| Vendor | Product | Versions |
|---|---|---|
Hillrom | Welch Allyn Q-Stress Cardiac Stress Testing System | affected 6.0.0 - <= 6.3.1 |
Hillrom | Welch Allyn X-Scribe Cardiac Stress Testing System | affected 5.01 - <= 6.3.1 |
Hillrom | Welch Allyn Diagnostic Cardiology Suite | affected 2.1.0 |
Hillrom | Welch Allyn Vision Express | affected 6.1.0 - <= 6.4.0 |
Hillrom | Welch Allyn H-Scribe Holter Analysis System | affected 5.01 - <= 6.4.0 |
Hillrom | Welch Allyn R-Scribe Resting ECG System | affected 5.01 - <= 7.0.0 |
Hillrom | Welch Allyn Connex Cardio | affected 1.0.0 - <= 1.1.1 |
Weaknesses (CWE)
CVSS v3.1 Details
CVSS v3.1 Vector
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Attack Vector
Attack Complexity
Privileges Required
User Interaction
Scope
Confidentiality
Integrity
Availability
References
Security Training
Train your team to recognize and prevent security threats with our comprehensive security awareness program.
Start TrainingVulnerability Scanning
Discover vulnerabilities in your applications and infrastructure before attackers do.
Scan Now